{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005302","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.072461+00:00","generated_at":"2026-05-27T00:55:24.749207+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Matinas BioPharma appoints Evelyn D'An as independent director and Audit Committee Chair","bullets":["Evelyn D'An appointed to board effective February 5, 2025 as independent director and Audit Committee Chair.","Ms. D'An is a former Ernst & Young partner with 18 years of experience, currently President of D'An Financial Services.","She also serves on boards of Zoomcar (ZCAR), Backblaze (BLZE), and GHD Group (private).","No related party transactions; compensated under standard non-employee director plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005302","json":"https://secwatch.observer/filing/0001493152-25-005302.json","markdown":"https://secwatch.observer/filing/0001493152-25-005302.md","text":"https://secwatch.observer/filing/0001493152-25-005302.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315225005302/0001493152-25-005302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315225005302/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:55:24.749207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}